Clinical Trial Update: PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy [NA]

View source ↗

Summary

An upcoming clinical trial is evaluating percutaneous coronary intervention with guideline-directed medical therapy for patients with heart failure with preserv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure with Preserved Ejection Fraction
• Ischemic Cardiomyopathy

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease | NA | Status: NOT_YET_RECRUITING